Reeves, Penny http://orcid.org/0000-0001-7335-8765
Edmunds, Kim
Szewczyk, Zoe
Grady, Alice
Yoong, Sze Lin
Wolfenden, Luke
Wyse, Rebecca
Finch, Meghan
Stacey, Fiona
Wiggers, John
Searles, Andrew
Funding for this research was provided by:
National Health and Medical Research Fund (APP1102943)
Cancer Council NSW (PG16-05)
Article History
Received: 24 June 2020
Accepted: 1 December 2020
First Online: 7 January 2021
Ethics approval and consent to participate
: Trial Registration: Australian New Zealand Clinical Trials Registry ACTRN12616000974404
: Not applicable.
: Ruby O’Rourke is Chief Executive Officer of Healthy Australia Ltd and HubHello Pty Ltd. David Salajan is the Head of Social Impact Program Development of Healthy Australia and HubHello Pty Ltd. The authors have no other competing interests to declare.